Century Therapeutics, Inc.
NASDAQ:IPSC
1.1 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -136.673 | -130.932 | -95.824 | -53.575 | -244.769 |
Depreciation & Amortization
| 13.044 | 8.44 | 3.748 | 1.402 | 0.249 |
Deferred Income Tax
| 0 | 0 | 0 | 4.722 | 0 |
Stock Based Compensation
| 14.622 | 10.669 | 4.662 | 0.876 | 0.147 |
Change In Working Capital
| 9.38 | 123.945 | -2.797 | 4.862 | 2.259 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -2.361 | -4.788 | -1.848 | 2.062 | 1.233 |
Other Working Capital
| 11.741 | 128.733 | -0.949 | 2.8 | 1.026 |
Other Non Cash Items
| 11.279 | 1.93 | 1.209 | 0.444 | 225.946 |
Operating Cash Flow
| -88.348 | 14.052 | -89.002 | -41.269 | -16.168 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -13.736 | -30.604 | -44.97 | -9.825 | -2.46 |
Acquisitions Net
| 0 | -238.218 | -30.336 | -4.722 | 24.166 |
Purchases Of Investments
| -209.034 | -254 | -330.034 | -49.86 | -41.54 |
Sales Maturities Of Investments
| 283.902 | 271.476 | 76.666 | 41.65 | -24.166 |
Other Investing Activites
| 0 | 238.218 | 30.336 | -4.722 | 24.166 |
Investing Cash Flow
| 61.132 | -13.128 | -298.338 | -22.757 | -19.834 |
Financing Activities: | |||||
Debt Repayment
| -10.241 | 0 | 0 | 9.734 | 0 |
Common Stock Issued
| 0.516 | 27.158 | 221.615 | 38.1 | 74.839 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0 | 0 | 196.159 | 37.956 | 74.839 |
Financing Cash Flow
| -9.725 | 27.158 | 417.774 | 47.69 | 74.839 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -36.941 | 28.082 | 30.434 | -16.336 | 38.837 |
Cash At End Of Period
| 49.303 | 86.244 | 58.162 | 27.728 | 70.261 |